Spontaneous clearance of hepatitis C virus (HCV) occurs in ~30% of acute infections. Host genetics play a major role in HCV clearance, with a strong effect of single nucleotide polymorphisms (SNPs) of the IL28B gene already found in different populations, mostly infected with viral genotypes 1 and 3. Egypt has the highest prevalence of HCV infection in the world, which is mostly due to viral genotype 4. We investigated the role of several IL28B SNPs in HCV spontaneous clearance in an Egyptian population. We selected nine SNPs within the IL28B genomic region covering the linkage disequilibrium (LD) block known to be associated with HCV clearance in European populations. These SNPs were genotyped in 261 HCV-infected Egyptian subjects (130 with spontaneous clearance and 131 with chronic infection). The most associated SNPs were rs12979860 (P = 1.6×10−7) and the non-synonymous IL28B SNP, rs8103142 (P = 1.6×10−7). Interestingly, three SNPs at the two bounds of the region were monomorphic, reducing the size of the LD block in which the causal variants are potentially located to ~20 kilobases. HCV clearance in Egypt was associated with a region of IL28B smaller than that identified in European populations, and involved the non-synonymous IL28B SNP, rs8103142.
Citation: Pedergnana V, Abdel-Hamid M, Guergnon J, Mohsen A, Le Fouler L, et al. (2012) Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus. PLoS ONE 7(6): e38578. doi:10.1371/journal.pone.0038578
Editor: Birke Bartosch, Inserm, U1052, UMR 5286, France
Received: February 17, 2012; Accepted: May 7, 2012; Published: June 14, 2012
Copyright: © 2012 Pedergnana et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the EC FP7 Coordinated Actions - The SPHINX Consortium, and the Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (Grant numbers ANRS 12107, 12122 and 12210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Hepatitis C virus (HCV) infects 170 million people worldwide and is thus a major Public Health problem , . End-stage chronic hepatitis C is the leading cause of liver transplantation in developed countries and more than 350,000 people die from HCV-related liver diseases each year , . Spontaneous clearance of hepatitis C virus (HCV) occurs in ~30% of acute infections , . Differences in HCV clearance and persistence have been associated with viral factors and several host factors, including ethnicity, age, sex and co-infection with human immunodeficiency virus or hepatitis B virus , . Host genetics also play a major role, with a strong effect of variants of the IL28B gene, which encodes IFN-λ3, on spontaneous HCV clearance reported in populations of different backgrounds, mostly infected with viral genotypes 1 and 3 (reviewed in ). The same IL28B variants are also strongly associated with HCV clearance under treatment , .
Egypt has the highest prevalence of HCV infection of any country in the world, with a seroprevalence ranging from 10% in children to 45% in adults , . More than 90% of HCV infections in Egypt involve genotype 4 , . One study recently reported an association between the most studied single nucleotide polymorphism (SNP) of IL28B, rs12979860, and the spontaneous clearance of HCV genotype 4 in an Egyptian sample . We investigated the role of a panel of IL28B SNPs in the spontaneous clearance of HCV in a larger Egyptian cohort. We found that the clearance effect was restricted to a region of IL28B smaller than that identified in European populations and that this effect also involved rs8103142, a non synonymous IL28B SNP.
This study combined data from two Egyptian cohorts. The first included 3994 individuals from a large epidemiological study in a village of the Nile delta, the details of which have been described elsewhere . Briefly, in this cohort 491 individuals (12.3%) were seropositive for HCV and 305 of them had positive PCR test. None of the seropositive individuals have been treated at the time of the study. Ninety-six RNA samples had previously been sequenced in this cohort, and 95 (99%) of these samples were of HCV genotype 4 . From the overall cohort, we selected 188 independent unrelated HCV-infected subjects defined on the basis of two positive serological tests . Individuals with positive PCR test for viral RNA were further classified as “chronically infected”, whereas those with negative results were considered to have cleared the virus spontaneously. Subjects of this cohort were not tested for HBV infection, but it could be noted that several studies in Nile Delta villages, including this one, reported a rather low prevalence on HBV infection (2%–8%) , , . The second cohort included 73 patients with symptomatic acute HCV infection recruited from Cairo hospitals in the context of a study that has been described elsewhere , . In these subjects, spontaneous clearance was defined as the loss of HCV RNA from the serum in the absence of treatment, based on two consecutive negative viral PCR results, together with subsequent negative tests, including at least one more than one year after the acute episode. Chronic infection was defined as the presence of HCV RNA in the serum in all PCR tests over a period of at least one year after the acute episode. Twenty-seven RNA samples from this cohort had previously been sequenced, and 24 (89%) were of HCV genotype 4 , . Subjects of this cohort were tested for HBV infection, as previously described , and out of the 73 present patients, only one was found to be HBV infected. Finally, the overall sample of 261 subjects consisted of 130 subjects with spontaneous clearance and 131 with chronic infection. All these subjects were not tested for HIV infection, but HIV seroprevalence was found to be quite low (<0.1%) in the general Egyptian population aged of 15 to 49 years (http://www.unaids.org/en/regionscountries/countries/egypt) as well as among injection drug users (~0.6%) . The study was approved by the Institutional Review Board of the Egyptian Ministry of Population and Health. Signed informed-consent documents were obtained from all study participants before they entered the study.
We genotyped a total of nine SNPs within the IL28B genomic region (Figure 1A). We first included the three SNPs (rs12980275, rs12979860, rs8099917) most frequently reported to be associated with HCV clearance in previous studies. We then explored the long-range linkage disequilibrium (LD) (500 kilobases on either side of IL28B) of these three SNPs, using the European CEU population available data from HapMap (http://www.hapmap.org) and 1000 Genomes project  databases. We selected the two most distant SNPs (rs958039, rs576832) in LD, with an r2>0.3, with any of the three initial SNPs. Within the chromosome 19 region defined by these two SNPs, we included three additional regularly spaced SNPs (rs4803217, rs4803222, rs10424607) in LD, with an r2>0.3, with any of the three initial SNPs. Finally, we also selected the non synonymous SNP rs8103142 not present in the public databases but reported to be in strong LD with rs12979860 in European populations . Illumina GoldenGate genotyping was carried out with VeraCode technology (Illumina). For genetic markers, we applied the following quality control criteria: call rate <90%, Hardy-Weinberg P-value<0.005 or low-quality genotype clustering. No individuals were excluded on the basis of genotyping call rate.
A. The top panel shows the IL28B genomic region bounded by rs958039 and rs576832, its position on chromosome 19 (39,730,301–39,759,282 base pairs), and the respective positions of the genotyped SNPs. The bottom panel shows the frequencies of the minor allele for each SNP in the European and Egyptian populations. European frequencies are estimated from the CEU data from Hapmap and the 1000 Genomes project. Egyptian frequencies are estimated from the population from the overall sample studied here and separately for the two groups of individuals (HCV clearance and HCV persistence). Odds ratio for HCV clearance (OR) and 95% confidence intervals (CI 95%), together with P-values for univariate tests with the additive genetic model are also shown for each SNP. B. Proportion of spontaneous clearance as a function of genotype at SNPs rs12979860 and rs8103142.
Univariate tests of association between the genotyped SNPs and the clearance/persistence status of HCV infection were carried out using PLINK software . Multivariate analysis was performed with the LOGISTIC procedure implemented in SAS software v.9.2 (SAS Institute, Cary, North Carolina, USA). Pairwise LD between SNPs and haplotype frequencies were estimated with PLINK  and Haploview 4.1 (http://www.broad.mit.edu/mpg/haploview) software.
All the SNPs studied satisfied the quality control filters in all 261 individuals, and the allelic frequencies are reported in figure 1A. Three SNPs at the 3′ (rs958039) and the 5′ (rs10424607 and rs576832) boundaries of the IL28B region were monomorphic, whereas the frequencies of the other SNPs were similar to those observed in European populations. Univariate association analyses showed that the six polymorphic SNPs in the Egyptian population were strongly associated with spontaneous HCV clearance (Figure 1A). The most significant results were obtained with an additive genetic model, with rs12979860 [odds ratio of presenting HCV clearance (OR) for CT vs.TT (or CC vs.CT) = 2.84 (95% confidence interval: 1.87–4.30); P = 1.6×10−7] and rs8103142 [OR = 2.76 (1.84–4.13); P = 1.6×10−7]. Association analyses conducted for these two SNPs separately in our two cohorts provided very similar results in terms of allele frequencies and odds-ratios indicating that possible HBV co-infection in some patients of our first cohort could not affect these results. In our whole sample, and taking rs8103142 as an example, the proportion of subjects with HCV clearance was much higher in subjects carrying the protective TT genotype (66% of clearers) than in those with CT (39% of clearers) or CC (23% of clearers) genotypes (Figure 1B).
We then carried out multivariate regression analysis with the six polymorphic SNPs. When the most significant SNP (rs12979860) was introduced into the model, the other five SNPs ceased to be significantly associated with clearance, confirming that this association was based on a single signal. We then estimated pairwise LD between the six polymorphic SNPs. The LD pattern of these SNPs, and that of rs12979860 in particular (see Figure S1A), in this Egyptian population was similar to that in European populations (see Figure S1B). The non-synonymous SNP rs8103142 could not be included in this comparison, as no genotyping data were available for the CEU population. The r2 for the relationship between rs8103142 and rs12979860 was estimated at 0.96 in another European population  and 0.88 in our Egyptian population. The three remaining SNPs were monomorphic in the Egyptian population, whereas they form part of the IL28B cluster associated with HCV clearance in the European population (Figure 1A). Interestingly, these three SNPs are located at the 3′ (rs958039) and 5′ (rs10424607 and rs576832) ends of the genomic region corresponding to IL28B (Figure 1A), reducing the size of the LD block in the Egyptian population by about one third. Overall, these observations suggest that the causal SNPs underlying the association with HCV clearance are located in a smaller region of ~20 kilobases located between rs958039 and rs10424607 rather than in a long-range LD block.
Finally, we estimated haplotype frequencies derived from the six polymorphic SNPs in this population. The objective of this haplotype analysis was not to test formally for differences in haplotype frequencies between subjects with clearance and those with chronic infection, but to further refine our univariate results by providing the general haplotype structure of this Egyptian sample. Seven haplotypes had an estimated frequency >0.02 in the whole sample. Based on differences in haplotype frequencies between subjects with spontaneous clearance and those with chronic infection, these seven haplotypes could be classified into two protective (favouring clearance) haplotypes (one of which was much more common than the other) and five “at risk” haplotypes (conferring a predisposition to chronic infection) (Figure 2). The two protective haplotypes differed only in terms of the allele of SNP rs4803217. In comparisons with the alleles present in the two protective haplotypes, only two SNPs presented the alternative allele in all five at risk haplotypes, discrepancies being observed for the others. The two SNPs with consistently different alleles between the protective and at risk haplotypes were rs12979860 and rs8103142, the non-synonymous SNP. This observation is consistent with the univariate association results and supports the view that the core of the association is dependent on these two SNPs, the effect of which are indistinguishable in this sample.
Haplotype frequencies are given for each of the two groups: individuals with persistent infection (“Chronic infection”) and individuals who cleared the infection (“Spontaneous clearance”). As defined in the text, the protective haplotypes (1 and 2) favour HCV clearance, whereas the “at risk” haplotypes (3 to 7) confer a predisposition to chronic HCV infection. The more frequent protective haplotype (haplotype 1) could be defined as the reference protective haplotype, while the more frequent “at risk” haplotype (haplotype 3), which is composed of the exact opposite alleles for all SNPs of haplotype 1, could be defined as the reference “at risk” haplotype. The dashed-line circles show discrepancies within the two protective haplotypes, i.e. between haplotype 2 and the reference protective haplotype 1. The dashed-line squares show discrepancies within the “at risk” haplotypes, i.e. between haplotypes 4–7 and the reference “at risk” haplotype 3. Only two SNPs identified by the solid-line rectangle (rs8103142 and rs12979860) shows have the same allele for the two protective haplotypes and the alternative allele in all the five at risk haplotypes.
These results confirm the major role of IL28B variants in the spontaneous clearance of HCV genotype 4 infection in an Egyptian population. In particular, the magnitude of the association with rs12979860 observed is similar to that reported in many studies conducted on HCV genotype 1 infection ,  and with the only previous study of HCV genotype 4 infection in an Egyptian population . Our refined analysis, including eight additional IL28B SNPs, showed that the LD block of the IL28B SNP cluster associated with HCV clearance was shorter than that in European populations. In particular, this analysis reduces the chromosomal region in which the causal SNPs are potentially located to about 20 kilobases of the IL28B genomic region, excluding the IL28A genomic region. Finally, both our univariate and haplotype analyses clearly showed that the core association depended on two SNPs, rs12979860 and rs8103142. SNP rs8103142 replaces a lysine residue by an arginine residue at position 70 (K70R) in IFN-λ3, a substitution predicted to be benign by Polyphen . Further functional studies are required to identify the causal SNPs underlying this strong association and the precise mechanisms of IL28B involvement in HCV infection.
Linkage disequilibrium pattern for the six polymorphic SNPs in the Egyptian and European populations. Panel A shows linkage disequilibrium (LD) in terms of r2 values between rs12979860 and the eight other genotyped SNPs in two different populations (Egyptian/European). European r2 values were estimated from the CEU data from Hapmap and the 1000 Genomes project, Egyptian values were estimated from our overall sample. No data for rs8103142 were available for the CEU population, so the r2 value for this SNP could not be estimated for the European population. The SNPs rs955155, rs10424607 and rs576832 were monomorphic in the Egyptian population, and it was therefore not possible to estimate r2 values for these SNPs in the Egyptian population. Panel B shows the pairwise r2 for combinations of the six polymorphic SNPs of the IL28B genomic region in both the Egyptian population (first value) and the CEU European population (second value). No data for rs8103142 were available for the CEU population. Differences of less than 10% between the two r2 values are indicated in dark grey; differences of less than 25% are shown in light grey and differences of more than 25% are shown in white.
We thank Jean-Laurent Casanova and all members of both branches of the laboratory of Human Genetics of Infectious Diseases. We thank Matthew Albert for continuous support and fruitful discussions.
Conceived and designed the experiments: MAH AF SP LA. Performed the experiments: JG IT MAH AM. Analyzed the data: VP LLF SP LA. Wrote the paper: VP LA. Participated in the collection of data, and the interpretation of clinical data: MAH MKM AF SP.
- 1. World Health Organisation website. Accessed 2012 May 23.
- 2. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, et al. (2000) The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama 284: 450–456.
- 3. Balagopal A, Thomas DL, Thio CL (2010) IL28B and the control of hepatitis C virus infection. Gastroenterology 139: 1865–1876.
- 4. Rauch A, Gaudieri S, Thio C, Bochud PY (2009) Host genetic determinants of spontaneous hepatitis C clearance. Pharmacogenomics 10: 1819–1837.
- 5. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798–801.
- 6. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100–1104.
- 7. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105–1109.
- 8. Guerra J, Garenne M, Mohamed MK, Fontanet A HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat, In press.
- 9. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, et al. (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 31: 61–80.
- 10. Kurbanov F, Abdel-Hamid M, Latanich R, Astemborski J, Mohamed M, et al. (2011) Genetic Polymorphism in IL28B Is Associated With Spontaneous Clearance of Hepatitis C Virus Genotype 4 Infection in an Egyptian Cohort. J Infect Dis 204: 1391–1394.
- 11. Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, et al. (2008) Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut 57: 1268–1274.
- 12. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, et al. (2001) Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg 64: 147–153.
- 13. Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, et al. (2006) HCV-related morbidity in a rural community of Egypt. J Med Virol 78: 1185–1189.
- 14. Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, et al. (2002) Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67: 436–442.
- 15. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, et al. (2005) Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 76: 520–525.
- 16. Paez Jimenez A, Sharaf Eldin N, Rimlinger F, El-Daly M, El-Hariri H, et al. (2010) HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 59: 1554–1560.
- 17. Paez Jimenez A, Mohamed MK, Eldin NS, Seif HA, El Aidi S, et al. (2009) Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One 4: e7193.
- 18. Soliman C, Rahman IA, Shawky S, Bahaa T, Elkamhawi S, et al. (2010) HIV prevalence and risk behaviors of male injection drug users in Cairo, Egypt. Aids 24: S33–38.
- 19. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.
- 20. di Iulio J, Ciuffi A, Fitzmaurice K, Kelleher D, Rotger M, et al. (2011) Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 53: 1446–1454.
- 21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.
- 22. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30: 3894–3900.